Humana Inc. Plans Quarterly Dividend of $0.89 (NYSE:HUM)

Humana Inc. (NYSE:HUM) announced a quarterly dividend on Thursday, August 15th, RTT News reports. Stockholders of record on Monday, September 30th will be paid a dividend of 0.885 per share by the insurance provider on Friday, October 25th. This represents a $3.54 annualized dividend and a dividend yield of 1.11%. The ex-dividend date of this dividend is Monday, September 30th.

Humana has increased its dividend by an average of 12.3% annually over the last three years. Humana has a payout ratio of 17.7% meaning its dividend is sufficiently covered by earnings. Analysts expect Humana to earn $19.69 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 18.0%.

Humana Trading Up 2.1 %

Shares of NYSE HUM opened at $319.57 on Friday. Humana has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. The business’s 50 day moving average is $349.94 and its two-hundred day moving average is $344.48. The stock has a market capitalization of $38.51 billion, a P/E ratio of 19.90, a PEG ratio of 2.44 and a beta of 0.50.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. Humana’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $8.94 EPS. As a group, research analysts expect that Humana will post 16.01 EPS for the current year.

Analyst Ratings Changes

Several brokerages have issued reports on HUM. Royal Bank of Canada raised their price objective on shares of Humana from $385.00 to $400.00 and gave the stock an “outperform” rating in a research note on Thursday, September 5th. TD Cowen raised their price target on Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 price objective on shares of Humana in a research report on Friday, September 20th. Truist Financial lifted their target price on Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. Finally, Morgan Stanley began coverage on shares of Humana in a report on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target on the stock. Thirteen analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $398.70.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.